Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Crohn Disease | 60 | 2024 | 2285 | 5.620 |
Why?
|
Inflammatory Bowel Diseases | 48 | 2024 | 2432 | 4.890 |
Why?
|
Colitis, Ulcerative | 36 | 2024 | 1918 | 2.910 |
Why?
|
Gastrointestinal Agents | 8 | 2021 | 511 | 1.650 |
Why?
|
Complementary Therapies | 3 | 2017 | 486 | 1.220 |
Why?
|
Tumor Necrosis Factor-alpha | 12 | 2022 | 4348 | 1.170 |
Why?
|
Feces | 11 | 2024 | 1505 | 0.930 |
Why?
|
Cholangitis, Sclerosing | 2 | 2024 | 179 | 0.750 |
Why?
|
Phytotherapy | 3 | 2018 | 297 | 0.750 |
Why?
|
Antibodies, Monoclonal | 16 | 2021 | 9243 | 0.720 |
Why?
|
Immunosuppressive Agents | 8 | 2019 | 4215 | 0.710 |
Why?
|
Irritable Bowel Syndrome | 3 | 2023 | 454 | 0.670 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 8 | 2009 | 141 | 0.650 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 8 | 2018 | 2270 | 0.640 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 5 | 2006 | 891 | 0.610 |
Why?
|
Autoimmune Diseases | 4 | 2019 | 2249 | 0.610 |
Why?
|
Azathioprine | 3 | 2016 | 354 | 0.590 |
Why?
|
Esophagitis, Peptic | 1 | 2017 | 77 | 0.540 |
Why?
|
Bile Acids and Salts | 2 | 2024 | 398 | 0.530 |
Why?
|
Immunity, Innate | 6 | 2014 | 3078 | 0.530 |
Why?
|
Legislation, Drug | 1 | 2018 | 216 | 0.530 |
Why?
|
Immunologic Factors | 5 | 2017 | 1594 | 0.530 |
Why?
|
Integrative Medicine | 1 | 2017 | 87 | 0.510 |
Why?
|
Immunoglobulin Fab Fragments | 3 | 2013 | 446 | 0.510 |
Why?
|
Pouchitis | 2 | 2020 | 64 | 0.510 |
Why?
|
Drug Utilization | 2 | 2018 | 1187 | 0.470 |
Why?
|
Proctocolectomy, Restorative | 3 | 2023 | 191 | 0.460 |
Why?
|
Arthritis, Rheumatoid | 4 | 2019 | 3788 | 0.450 |
Why?
|
Dibutyl Phthalate | 3 | 2018 | 29 | 0.430 |
Why?
|
Decision Support Techniques | 5 | 2013 | 2007 | 0.420 |
Why?
|
Severity of Illness Index | 15 | 2024 | 15897 | 0.410 |
Why?
|
Gastric Juice | 1 | 2012 | 59 | 0.410 |
Why?
|
Remission Induction | 8 | 2021 | 2413 | 0.400 |
Why?
|
Colonoscopy | 7 | 2024 | 1409 | 0.400 |
Why?
|
Gastric Acid | 1 | 2012 | 98 | 0.390 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2017 | 2156 | 0.390 |
Why?
|
Polyethylene Glycols | 3 | 2013 | 1189 | 0.390 |
Why?
|
Intestinal Fistula | 3 | 2020 | 146 | 0.380 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2016 | 463 | 0.370 |
Why?
|
Adult | 76 | 2024 | 223253 | 0.360 |
Why?
|
Histamine H2 Antagonists | 1 | 2012 | 167 | 0.360 |
Why?
|
Colectomy | 2 | 2013 | 696 | 0.350 |
Why?
|
Probiotics | 4 | 2009 | 387 | 0.350 |
Why?
|
Humans | 132 | 2024 | 766432 | 0.350 |
Why?
|
Psoriasis | 2 | 2024 | 925 | 0.340 |
Why?
|
Anti-Inflammatory Agents | 5 | 2011 | 1805 | 0.340 |
Why?
|
Medical History Taking | 1 | 2013 | 778 | 0.330 |
Why?
|
Research Subjects | 1 | 2012 | 248 | 0.330 |
Why?
|
Environmental Exposure | 4 | 2019 | 4544 | 0.330 |
Why?
|
Appendectomy | 3 | 2008 | 445 | 0.330 |
Why?
|
Young Adult | 33 | 2024 | 59928 | 0.320 |
Why?
|
Clostridium Infections | 1 | 2016 | 563 | 0.320 |
Why?
|
Secondary Prevention | 4 | 2011 | 1468 | 0.310 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2010 | 219 | 0.310 |
Why?
|
Middle Aged | 59 | 2024 | 223127 | 0.310 |
Why?
|
Registries | 6 | 2024 | 8344 | 0.300 |
Why?
|
Male | 78 | 2024 | 363975 | 0.300 |
Why?
|
Intestines | 7 | 2022 | 1904 | 0.300 |
Why?
|
Medical Records | 1 | 2013 | 1408 | 0.300 |
Why?
|
Anus Diseases | 2 | 2020 | 53 | 0.300 |
Why?
|
Patient Readmission | 3 | 2017 | 3282 | 0.290 |
Why?
|
Suicidal Ideation | 1 | 2017 | 1466 | 0.280 |
Why?
|
Female | 78 | 2024 | 396354 | 0.280 |
Why?
|
Dietary Fiber | 2 | 2013 | 767 | 0.280 |
Why?
|
Mesalamine | 4 | 2018 | 133 | 0.280 |
Why?
|
Metabolome | 1 | 2024 | 1009 | 0.280 |
Why?
|
Proton Pump Inhibitors | 1 | 2012 | 550 | 0.270 |
Why?
|
Colon | 5 | 2022 | 1798 | 0.270 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1383 | 0.270 |
Why?
|
Suicide | 1 | 2017 | 1606 | 0.270 |
Why?
|
Diverticulitis | 1 | 2008 | 187 | 0.260 |
Why?
|
Intestinal Polyposis | 1 | 2005 | 42 | 0.250 |
Why?
|
Toothpastes | 1 | 2005 | 12 | 0.250 |
Why?
|
Vitamin D | 2 | 2017 | 3270 | 0.250 |
Why?
|
Patient Selection | 1 | 2017 | 4248 | 0.240 |
Why?
|
Diverticulitis, Colonic | 1 | 2006 | 140 | 0.240 |
Why?
|
Helminthiasis | 1 | 2005 | 81 | 0.230 |
Why?
|
Attitude to Health | 2 | 2012 | 2021 | 0.230 |
Why?
|
Case-Control Studies | 11 | 2017 | 22245 | 0.220 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2006 | 319 | 0.220 |
Why?
|
Hospitalization | 4 | 2017 | 10812 | 0.220 |
Why?
|
Cutaneous Fistula | 2 | 2004 | 79 | 0.220 |
Why?
|
Hydrogen | 1 | 2024 | 168 | 0.220 |
Why?
|
Metagenome | 3 | 2012 | 464 | 0.220 |
Why?
|
Cathartics | 1 | 2024 | 129 | 0.210 |
Why?
|
Intestinal Mucosa | 8 | 2020 | 3048 | 0.210 |
Why?
|
Mind-Body Therapies | 2 | 2017 | 294 | 0.210 |
Why?
|
Self Report | 2 | 2013 | 3770 | 0.210 |
Why?
|
Patient Participation | 1 | 2012 | 1446 | 0.200 |
Why?
|
Ileum | 3 | 2024 | 558 | 0.200 |
Why?
|
Colitis | 4 | 2020 | 1241 | 0.200 |
Why?
|
Integrin alpha4 | 2 | 2013 | 89 | 0.200 |
Why?
|
Depression | 3 | 2018 | 8229 | 0.200 |
Why?
|
Progestins | 1 | 2024 | 300 | 0.200 |
Why?
|
Colonic Pouches | 1 | 2023 | 122 | 0.200 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2005 | 633 | 0.200 |
Why?
|
Herbicides | 1 | 2022 | 104 | 0.190 |
Why?
|
Length of Stay | 1 | 2015 | 6490 | 0.190 |
Why?
|
Cost of Illness | 2 | 2024 | 1949 | 0.190 |
Why?
|
Internet | 1 | 2013 | 3111 | 0.190 |
Why?
|
Pilot Projects | 5 | 2023 | 8720 | 0.190 |
Why?
|
Carcinoma, Small Cell | 1 | 2023 | 419 | 0.180 |
Why?
|
Diarrhea | 2 | 2017 | 1317 | 0.180 |
Why?
|
Efficiency | 1 | 2024 | 479 | 0.180 |
Why?
|
Chenodeoxycholic Acid | 1 | 2020 | 34 | 0.180 |
Why?
|
Risk Factors | 22 | 2019 | 74828 | 0.180 |
Why?
|
Immunologic Deficiency Syndromes | 2 | 2005 | 548 | 0.180 |
Why?
|
Retrospective Studies | 20 | 2024 | 81588 | 0.180 |
Why?
|
Environment | 2 | 2022 | 1120 | 0.180 |
Why?
|
Prognosis | 10 | 2019 | 29922 | 0.170 |
Why?
|
Adolescent | 26 | 2019 | 88898 | 0.170 |
Why?
|
Cohort Studies | 13 | 2022 | 41703 | 0.170 |
Why?
|
Drug Therapy, Combination | 5 | 2017 | 6306 | 0.170 |
Why?
|
Treatment Outcome | 18 | 2023 | 65202 | 0.160 |
Why?
|
Prospective Studies | 17 | 2024 | 54826 | 0.160 |
Why?
|
End Stage Liver Disease | 1 | 2024 | 369 | 0.160 |
Why?
|
Drug Carriers | 2 | 2020 | 702 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 5 | 2016 | 6508 | 0.160 |
Why?
|
Abdominal Muscles | 1 | 2000 | 172 | 0.160 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2014 | 264 | 0.160 |
Why?
|
Aged | 33 | 2024 | 171234 | 0.160 |
Why?
|
Quality-Adjusted Life Years | 5 | 2013 | 1740 | 0.150 |
Why?
|
Denmark | 2 | 2019 | 774 | 0.150 |
Why?
|
Yogurt | 1 | 1998 | 71 | 0.150 |
Why?
|
Patient Compliance | 1 | 2008 | 2694 | 0.150 |
Why?
|
Gonadal Hormones | 1 | 2017 | 29 | 0.150 |
Why?
|
Models, Immunological | 1 | 2000 | 517 | 0.150 |
Why?
|
Gonadotropins, Pituitary | 1 | 2017 | 70 | 0.150 |
Why?
|
Inflammation | 4 | 2022 | 10860 | 0.140 |
Why?
|
Plasticizers | 1 | 2017 | 52 | 0.140 |
Why?
|
Aged, 80 and over | 14 | 2019 | 59538 | 0.140 |
Why?
|
Constriction, Pathologic | 2 | 2022 | 1103 | 0.140 |
Why?
|
Endocrine Glands | 1 | 2017 | 101 | 0.140 |
Why?
|
Boston | 4 | 2019 | 9333 | 0.140 |
Why?
|
Follow-Up Studies | 14 | 2018 | 39283 | 0.140 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2018 | 193 | 0.140 |
Why?
|
Epistaxis | 2 | 2009 | 117 | 0.140 |
Why?
|
Drug Delivery Systems | 2 | 2020 | 2210 | 0.130 |
Why?
|
Health Surveys | 3 | 2017 | 4054 | 0.130 |
Why?
|
Nod2 Signaling Adaptor Protein | 2 | 2007 | 86 | 0.130 |
Why?
|
Gastrointestinal Hemorrhage | 4 | 2009 | 1126 | 0.130 |
Why?
|
Multivariate Analysis | 7 | 2019 | 12061 | 0.130 |
Why?
|
Metabolic Networks and Pathways | 2 | 2018 | 800 | 0.130 |
Why?
|
Bacteria | 3 | 2024 | 2212 | 0.130 |
Why?
|
Sulfonamides | 1 | 2006 | 1978 | 0.130 |
Why?
|
T-Lymphocytes | 7 | 2022 | 10263 | 0.130 |
Why?
|
Metabolomics | 2 | 2016 | 1675 | 0.130 |
Why?
|
Thyroid Hormones | 1 | 2018 | 408 | 0.120 |
Why?
|
Pyrazoles | 1 | 2006 | 2029 | 0.120 |
Why?
|
Gastrointestinal Tract | 2 | 2012 | 834 | 0.120 |
Why?
|
Sperm Motility | 1 | 2016 | 264 | 0.120 |
Why?
|
Recombinant Proteins | 4 | 2006 | 6507 | 0.120 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2018 | 364 | 0.120 |
Why?
|
Ostomy | 1 | 2014 | 34 | 0.120 |
Why?
|
Cholestenones | 1 | 2024 | 6 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10379 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2158 | 0.120 |
Why?
|
Heparin | 2 | 2020 | 1634 | 0.120 |
Why?
|
British Columbia | 2 | 2012 | 239 | 0.120 |
Why?
|
Erectile Dysfunction | 1 | 2018 | 437 | 0.110 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2016 | 1044 | 0.110 |
Why?
|
International Agencies | 1 | 2015 | 244 | 0.110 |
Why?
|
Rectal Fistula | 3 | 2005 | 76 | 0.110 |
Why?
|
Anti-Bacterial Agents | 6 | 2016 | 7475 | 0.110 |
Why?
|
Intestine, Small | 2 | 1998 | 1217 | 0.110 |
Why?
|
Semen | 1 | 2016 | 349 | 0.110 |
Why?
|
Smad3 Protein | 1 | 2014 | 165 | 0.110 |
Why?
|
Phenols | 1 | 2017 | 526 | 0.110 |
Why?
|
Diet | 4 | 2019 | 8085 | 0.110 |
Why?
|
Butyrates | 1 | 2024 | 164 | 0.110 |
Why?
|
Nitric Oxide | 1 | 2022 | 2141 | 0.110 |
Why?
|
Metagenomics | 2 | 2024 | 473 | 0.110 |
Why?
|
Superoxides | 1 | 2014 | 388 | 0.110 |
Why?
|
Bacteroides | 2 | 2010 | 165 | 0.100 |
Why?
|
Acupuncture Therapy | 1 | 2017 | 467 | 0.100 |
Why?
|
Anxiety | 2 | 2019 | 4671 | 0.100 |
Why?
|
Digestive System Surgical Procedures | 2 | 2016 | 584 | 0.100 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2020 | 2477 | 0.100 |
Why?
|
Intestinal Obstruction | 1 | 2016 | 433 | 0.100 |
Why?
|
Gastric Acidity Determination | 1 | 2012 | 56 | 0.100 |
Why?
|
Regression Analysis | 2 | 2019 | 6327 | 0.100 |
Why?
|
Time Factors | 8 | 2017 | 40116 | 0.100 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 26294 | 0.100 |
Why?
|
Antibodies, Antinuclear | 2 | 2011 | 340 | 0.100 |
Why?
|
Mucous Membrane | 2 | 2013 | 658 | 0.100 |
Why?
|
Stomach | 1 | 1996 | 700 | 0.100 |
Why?
|
Hospitals, University | 1 | 2013 | 571 | 0.100 |
Why?
|
Biological Therapy | 1 | 2013 | 140 | 0.090 |
Why?
|
Child | 14 | 2019 | 80668 | 0.090 |
Why?
|
Cost-Benefit Analysis | 4 | 2013 | 5535 | 0.090 |
Why?
|
Logistic Models | 5 | 2017 | 13276 | 0.090 |
Why?
|
Neutrophils | 3 | 2014 | 3782 | 0.090 |
Why?
|
Recurrence | 3 | 2016 | 8478 | 0.090 |
Why?
|
Fusobacteria | 1 | 2010 | 6 | 0.090 |
Why?
|
Blood Vessels | 1 | 1996 | 1111 | 0.090 |
Why?
|
Acetylesterase | 1 | 2010 | 14 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2015 | 550 | 0.090 |
Why?
|
Proteobacteria | 1 | 2010 | 47 | 0.090 |
Why?
|
Quality of Life | 7 | 2023 | 13472 | 0.090 |
Why?
|
DNA, Bacterial | 3 | 2010 | 1476 | 0.090 |
Why?
|
Sickness Impact Profile | 1 | 2011 | 299 | 0.090 |
Why?
|
Cecum | 1 | 2011 | 231 | 0.090 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 2010 | 98 | 0.090 |
Why?
|
Actinobacteria | 1 | 2010 | 62 | 0.090 |
Why?
|
Arteriovenous Malformations | 2 | 2005 | 396 | 0.090 |
Why?
|
Cytokines | 3 | 2013 | 7436 | 0.080 |
Why?
|
Gonadal Steroid Hormones | 1 | 2014 | 706 | 0.080 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2010 | 174 | 0.080 |
Why?
|
Germ-Line Mutation | 2 | 2010 | 1885 | 0.080 |
Why?
|
Decision Trees | 1 | 2011 | 508 | 0.080 |
Why?
|
Proportional Hazards Models | 5 | 2015 | 12527 | 0.080 |
Why?
|
Life Style | 2 | 2019 | 3926 | 0.080 |
Why?
|
United States | 11 | 2020 | 72910 | 0.080 |
Why?
|
Fatty Acids | 1 | 2017 | 1807 | 0.080 |
Why?
|
Psychometrics | 1 | 2018 | 3060 | 0.080 |
Why?
|
Activin Receptors, Type II | 1 | 2009 | 122 | 0.080 |
Why?
|
Nanoparticles | 1 | 2020 | 1966 | 0.080 |
Why?
|
Smad4 Protein | 2 | 2009 | 194 | 0.080 |
Why?
|
Reproducibility of Results | 6 | 2024 | 20129 | 0.080 |
Why?
|
Withholding Treatment | 1 | 2013 | 619 | 0.080 |
Why?
|
Drug Eruptions | 1 | 2011 | 335 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2014 | 6212 | 0.080 |
Why?
|
Macrophages | 3 | 2015 | 5782 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2017 | 3852 | 0.070 |
Why?
|
Environmental Pollutants | 1 | 2017 | 1294 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1447 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3229 | 0.070 |
Why?
|
Cannabis | 1 | 2013 | 446 | 0.070 |
Why?
|
Lithostathine | 1 | 2006 | 5 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 453 | 0.070 |
Why?
|
Vitamins | 1 | 2015 | 1630 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2016 | 1673 | 0.070 |
Why?
|
Reference Values | 1 | 2014 | 4913 | 0.070 |
Why?
|
Diverticulosis, Colonic | 1 | 2006 | 9 | 0.070 |
Why?
|
Adolescent Health Services | 1 | 2009 | 217 | 0.070 |
Why?
|
Nutrition Disorders | 2 | 1998 | 203 | 0.070 |
Why?
|
Trichuriasis | 1 | 2006 | 24 | 0.070 |
Why?
|
Vitamin D Deficiency | 2 | 2015 | 1348 | 0.070 |
Why?
|
Trichuris | 1 | 2006 | 32 | 0.070 |
Why?
|
DNA Fingerprinting | 1 | 2006 | 114 | 0.070 |
Why?
|
Insurance Coverage | 1 | 2017 | 1945 | 0.070 |
Why?
|
Longitudinal Studies | 3 | 2020 | 14760 | 0.070 |
Why?
|
Smoking | 4 | 2014 | 9076 | 0.060 |
Why?
|
Computational Biology | 1 | 2018 | 3564 | 0.060 |
Why?
|
Health Behavior | 1 | 2017 | 2649 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3690 | 0.060 |
Why?
|
Treatment Failure | 4 | 2015 | 2653 | 0.060 |
Why?
|
Paratuberculosis | 1 | 2005 | 5 | 0.060 |
Why?
|
Developing Countries | 1 | 1998 | 2913 | 0.060 |
Why?
|
Adolescent Development | 1 | 2009 | 273 | 0.060 |
Why?
|
Refrigeration | 1 | 2005 | 27 | 0.060 |
Why?
|
Mycobacterium avium | 1 | 2005 | 30 | 0.060 |
Why?
|
Gene Expression Profiling | 3 | 2015 | 9521 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2520 | 0.060 |
Why?
|
Filgrastim | 1 | 2005 | 132 | 0.060 |
Why?
|
Anastomosis, Surgical | 2 | 2023 | 992 | 0.060 |
Why?
|
Celiac Disease | 1 | 2013 | 820 | 0.060 |
Why?
|
Databases, Factual | 5 | 2022 | 8061 | 0.060 |
Why?
|
Liver Diseases | 2 | 2005 | 1303 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2017 | 3208 | 0.060 |
Why?
|
Cell Survival | 1 | 2014 | 5741 | 0.060 |
Why?
|
Chronic Disease | 2 | 2017 | 9352 | 0.060 |
Why?
|
Fatigue | 1 | 2011 | 1554 | 0.060 |
Why?
|
Risk Assessment | 5 | 2019 | 24272 | 0.060 |
Why?
|
Pentoxifylline | 1 | 2004 | 53 | 0.060 |
Why?
|
Growth Substances | 1 | 2006 | 759 | 0.060 |
Why?
|
Lactobacillus | 1 | 2005 | 212 | 0.060 |
Why?
|
Intestinal Absorption | 1 | 2005 | 400 | 0.060 |
Why?
|
Influenza Vaccines | 1 | 2011 | 780 | 0.060 |
Why?
|
Pregnanolone | 1 | 2024 | 67 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 4055 | 0.050 |
Why?
|
Survival Rate | 2 | 2015 | 12825 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3928 | 0.050 |
Why?
|
Health Status Indicators | 1 | 2009 | 968 | 0.050 |
Why?
|
Vascular Malformations | 1 | 2009 | 469 | 0.050 |
Why?
|
Motor Activity | 1 | 2013 | 2711 | 0.050 |
Why?
|
Animals | 14 | 2024 | 168887 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2019 | 4527 | 0.050 |
Why?
|
Reoperation | 1 | 2014 | 4323 | 0.050 |
Why?
|
Psychophysiologic Disorders | 1 | 2005 | 222 | 0.050 |
Why?
|
Toll-Like Receptors | 1 | 2006 | 582 | 0.050 |
Why?
|
Child, Preschool | 5 | 2019 | 42576 | 0.050 |
Why?
|
Intestinal Neoplasms | 1 | 2005 | 314 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2005 | 794 | 0.050 |
Why?
|
Measles | 1 | 2005 | 180 | 0.050 |
Why?
|
Biopsy | 2 | 2015 | 6778 | 0.050 |
Why?
|
Odds Ratio | 5 | 2016 | 9654 | 0.050 |
Why?
|
Absenteeism | 1 | 2024 | 247 | 0.050 |
Why?
|
Delayed-Action Preparations | 2 | 2020 | 966 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2013 | 5302 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2022 | 102 | 0.050 |
Why?
|
Safety | 2 | 2013 | 1157 | 0.050 |
Why?
|
Glycogen Storage Disease Type I | 1 | 2002 | 53 | 0.050 |
Why?
|
Osteonectin | 1 | 2022 | 33 | 0.050 |
Why?
|
Colorectal Neoplasms | 2 | 2016 | 6962 | 0.050 |
Why?
|
Autoimmunity | 1 | 2010 | 1356 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2014 | 3689 | 0.050 |
Why?
|
Gastroenterology | 1 | 2009 | 593 | 0.050 |
Why?
|
Interferon-gamma | 1 | 2010 | 3159 | 0.050 |
Why?
|
Autoantibodies | 1 | 2011 | 2115 | 0.050 |
Why?
|
Age Factors | 5 | 2013 | 18395 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2004 | 588 | 0.050 |
Why?
|
Wound Healing | 1 | 2013 | 2798 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2009 | 2741 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2015 | 12788 | 0.050 |
Why?
|
Antigens, CD | 2 | 2009 | 4031 | 0.050 |
Why?
|
Arthritis, Psoriatic | 1 | 2024 | 218 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2010 | 4850 | 0.050 |
Why?
|
Multigene Family | 1 | 2024 | 1081 | 0.050 |
Why?
|
Peristalsis | 1 | 2020 | 60 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2009 | 1390 | 0.050 |
Why?
|
Asia, Southeastern | 1 | 2020 | 115 | 0.040 |
Why?
|
Anal Canal | 1 | 2023 | 375 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2017 | 2108 | 0.040 |
Why?
|
Antibody Formation | 1 | 2005 | 1392 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2015 | 10740 | 0.040 |
Why?
|
Massachusetts | 1 | 2013 | 8885 | 0.040 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2022 | 223 | 0.040 |
Why?
|
Embolization, Therapeutic | 2 | 2000 | 1403 | 0.040 |
Why?
|
Hepatic Veins | 1 | 2000 | 112 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 454 | 0.040 |
Why?
|
Influenza, Human | 1 | 2011 | 1542 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2009 | 2815 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4566 | 0.040 |
Why?
|
Mice | 8 | 2024 | 81863 | 0.040 |
Why?
|
Contraceptives, Oral | 1 | 2002 | 559 | 0.040 |
Why?
|
NF-kappa B | 2 | 2022 | 2495 | 0.040 |
Why?
|
Infusions, Intravenous | 2 | 2004 | 2227 | 0.040 |
Why?
|
Hepatic Artery | 1 | 2000 | 233 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2019 | 26388 | 0.040 |
Why?
|
Postoperative Complications | 3 | 2011 | 15818 | 0.040 |
Why?
|
Thalidomide | 1 | 2004 | 886 | 0.040 |
Why?
|
Prevalence | 3 | 2017 | 15820 | 0.040 |
Why?
|
Models, Animal | 2 | 2020 | 2119 | 0.040 |
Why?
|
Double-Blind Method | 4 | 2015 | 12423 | 0.040 |
Why?
|
Rectum | 1 | 2023 | 896 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2014 | 18979 | 0.040 |
Why?
|
Ileal Diseases | 1 | 1998 | 70 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 11919 | 0.040 |
Why?
|
Rehydration Solutions | 1 | 1998 | 43 | 0.040 |
Why?
|
NAD | 1 | 2022 | 618 | 0.040 |
Why?
|
Duodenal Diseases | 1 | 1998 | 101 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4879 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2008 | 6845 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3795 | 0.040 |
Why?
|
Infant | 2 | 2019 | 36460 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 7057 | 0.040 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 1998 | 95 | 0.040 |
Why?
|
Dextran Sulfate | 1 | 1998 | 256 | 0.040 |
Why?
|
Food, Formulated | 1 | 1998 | 103 | 0.040 |
Why?
|
DNA | 1 | 2011 | 7207 | 0.030 |
Why?
|
Exercise | 1 | 2014 | 5943 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2014 | 16042 | 0.030 |
Why?
|
Parenteral Nutrition, Total | 1 | 1998 | 304 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2009 | 765 | 0.030 |
Why?
|
Incidence | 4 | 2020 | 21509 | 0.030 |
Why?
|
Air Pollution | 1 | 2010 | 2379 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18322 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2854 | 0.030 |
Why?
|
Constipation | 1 | 2020 | 568 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2018 | 751 | 0.030 |
Why?
|
Hypersensitivity | 1 | 2005 | 1169 | 0.030 |
Why?
|
Hospital Charges | 1 | 2017 | 345 | 0.030 |
Why?
|
Sperm Count | 1 | 2016 | 227 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11501 | 0.030 |
Why?
|
Rural Health | 1 | 1997 | 302 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6061 | 0.030 |
Why?
|
Lung Diseases | 1 | 2005 | 1941 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 2533 | 0.030 |
Why?
|
Radiography | 1 | 2005 | 6967 | 0.030 |
Why?
|
Comorbidity | 3 | 2017 | 10579 | 0.030 |
Why?
|
Donor Selection | 1 | 2016 | 242 | 0.030 |
Why?
|
Semen Analysis | 1 | 2016 | 235 | 0.030 |
Why?
|
Fluid Therapy | 1 | 1998 | 587 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2078 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2016 | 784 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 2 | 2015 | 1884 | 0.030 |
Why?
|
Helicobacter hepaticus | 1 | 2013 | 25 | 0.030 |
Why?
|
DNA Primers | 2 | 2009 | 2824 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 9611 | 0.030 |
Why?
|
Models, Biological | 2 | 2020 | 9458 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3198 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2016 | 525 | 0.030 |
Why?
|
Gene Expression | 2 | 2018 | 7583 | 0.030 |
Why?
|
Genes, rRNA | 1 | 2012 | 73 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2004 | 4559 | 0.020 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12979 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2013 | 251 | 0.020 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2012 | 92 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1791 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 1998 | 802 | 0.020 |
Why?
|
Phthalic Acids | 1 | 2016 | 485 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2272 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2017 | 935 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2022 | 2747 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2016 | 1866 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 2012 | 261 | 0.020 |
Why?
|
Zebrafish | 1 | 2022 | 3035 | 0.020 |
Why?
|
Apoptosis | 1 | 2006 | 9507 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2868 | 0.020 |
Why?
|
Swine | 1 | 2020 | 5981 | 0.020 |
Why?
|
Seasons | 1 | 2016 | 1521 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2012 | 4779 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2017 | 1735 | 0.020 |
Why?
|
Liver | 3 | 2000 | 7570 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8042 | 0.020 |
Why?
|
Biocatalysis | 1 | 2010 | 168 | 0.020 |
Why?
|
New England | 1 | 2013 | 1059 | 0.020 |
Why?
|
Clavulanic Acid | 1 | 2009 | 19 | 0.020 |
Why?
|
Eubacterium | 1 | 2009 | 23 | 0.020 |
Why?
|
Helicobacter Infections | 1 | 2013 | 390 | 0.020 |
Why?
|
Biodiversity | 1 | 2012 | 344 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2015 | 2002 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1752 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16721 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2006 | 6361 | 0.020 |
Why?
|
Terminology as Topic | 1 | 1996 | 1539 | 0.020 |
Why?
|
Clostridium | 1 | 2009 | 100 | 0.020 |
Why?
|
Mitochondria | 1 | 2022 | 3676 | 0.020 |
Why?
|
Chemokines | 1 | 2013 | 962 | 0.020 |
Why?
|
Women's Health | 1 | 2018 | 2080 | 0.020 |
Why?
|
Tyrosine | 1 | 2013 | 1425 | 0.020 |
Why?
|
RNA | 1 | 2018 | 2715 | 0.020 |
Why?
|
Decision Making | 1 | 2022 | 3955 | 0.020 |
Why?
|
Bifidobacterium | 1 | 2009 | 99 | 0.020 |
Why?
|
Speech Recognition Software | 1 | 2009 | 74 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2018 | 2192 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2013 | 886 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 18075 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2008 | 7869 | 0.020 |
Why?
|
Amoxicillin | 1 | 2009 | 179 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1765 | 0.020 |
Why?
|
Private Practice | 1 | 2009 | 154 | 0.020 |
Why?
|
Dexamethasone | 1 | 2015 | 1962 | 0.020 |
Why?
|
Enterobacteriaceae | 1 | 2009 | 161 | 0.020 |
Why?
|
Mesenteric Lymphadenitis | 1 | 2007 | 4 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2018 | 6020 | 0.020 |
Why?
|
Biological Transport | 1 | 2012 | 2083 | 0.020 |
Why?
|
Acetylation | 1 | 2010 | 1054 | 0.020 |
Why?
|
Demography | 1 | 2012 | 1641 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2920 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6259 | 0.020 |
Why?
|
B-Lymphocytes | 2 | 2010 | 4784 | 0.020 |
Why?
|
Sample Size | 1 | 2010 | 844 | 0.020 |
Why?
|
Fibroblast Growth Factor 10 | 1 | 2006 | 31 | 0.020 |
Why?
|
Genes, bcl-2 | 1 | 2006 | 119 | 0.020 |
Why?
|
Eating | 1 | 2013 | 1538 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2746 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6217 | 0.020 |
Why?
|
Genes, APC | 1 | 2006 | 144 | 0.020 |
Why?
|
Mothers | 1 | 1997 | 2208 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2470 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2055 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2009 | 1159 | 0.020 |
Why?
|
Amino Acids | 1 | 2012 | 1711 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7240 | 0.020 |
Why?
|
Genome, Human | 1 | 2018 | 4443 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2011 | 1560 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2011 | 2351 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2006 | 412 | 0.020 |
Why?
|
Cell Separation | 1 | 2010 | 1718 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2015 | 5502 | 0.010 |
Why?
|
Fatal Outcome | 2 | 2000 | 1838 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5789 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3427 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2006 | 1168 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1967 | 0.010 |
Why?
|
Phylogeny | 1 | 2012 | 2839 | 0.010 |
Why?
|
Exons | 1 | 2010 | 2392 | 0.010 |
Why?
|
Sweden | 1 | 2007 | 1382 | 0.010 |
Why?
|
Host-Parasite Interactions | 1 | 2006 | 303 | 0.010 |
Why?
|
Nurses | 1 | 2013 | 2503 | 0.010 |
Why?
|
Palliative Care | 1 | 1998 | 3640 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3427 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10092 | 0.010 |
Why?
|
DNA Damage | 1 | 2013 | 2464 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2006 | 948 | 0.010 |
Why?
|
Primary Prevention | 1 | 2011 | 1186 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5021 | 0.010 |
Why?
|
Iatrogenic Disease | 1 | 2006 | 551 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2015 | 3428 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3664 | 0.010 |
Why?
|
Drug Tolerance | 1 | 2004 | 365 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2011 | 2324 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30235 | 0.010 |
Why?
|
Postoperative Period | 1 | 2007 | 1824 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5872 | 0.010 |
Why?
|
Placebos | 1 | 2006 | 1659 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2014 | 2082 | 0.010 |
Why?
|
Administration, Oral | 1 | 2010 | 4014 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4428 | 0.010 |
Why?
|
Socioeconomic Factors | 2 | 2010 | 7840 | 0.010 |
Why?
|
Cardiac Output, High | 1 | 2000 | 6 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2012 | 3141 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13632 | 0.010 |
Why?
|
Endoscopy | 1 | 2011 | 1854 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2006 | 865 | 0.010 |
Why?
|
Perioperative Care | 1 | 2008 | 1043 | 0.010 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 2000 | 56 | 0.010 |
Why?
|
Appendicitis | 1 | 2007 | 680 | 0.010 |
Why?
|
Polyvinyl Alcohol | 1 | 2000 | 74 | 0.010 |
Why?
|
Liver Abscess | 1 | 2000 | 81 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5890 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2011 | 3211 | 0.010 |
Why?
|
Biliary Tract Diseases | 1 | 2000 | 159 | 0.010 |
Why?
|
Bile | 1 | 2000 | 300 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2006 | 2718 | 0.010 |
Why?
|
Gene Deletion | 1 | 2006 | 2668 | 0.010 |
Why?
|
Enterococcus | 1 | 2000 | 158 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2016 | 7866 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2000 | 1305 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6894 | 0.010 |
Why?
|
North America | 1 | 2002 | 1287 | 0.010 |
Why?
|
Mutation | 2 | 2016 | 30220 | 0.010 |
Why?
|
Hypertension, Portal | 1 | 2000 | 229 | 0.010 |
Why?
|
Risk | 1 | 2010 | 9601 | 0.010 |
Why?
|
Liver Failure | 1 | 2000 | 252 | 0.010 |
Why?
|
Software | 1 | 2012 | 4464 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2006 | 1814 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14466 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2000 | 340 | 0.010 |
Why?
|
Sclerotherapy | 1 | 1998 | 183 | 0.010 |
Why?
|
Kwashiorkor | 1 | 1997 | 24 | 0.010 |
Why?
|
Lymphoma | 1 | 2006 | 1900 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 1998 | 527 | 0.010 |
Why?
|
Esophageal and Gastric Varices | 1 | 1998 | 215 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15563 | 0.010 |
Why?
|
Genetic Testing | 1 | 2009 | 3590 | 0.010 |
Why?
|
Protein-Energy Malnutrition | 1 | 1997 | 189 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 13045 | 0.010 |
Why?
|
Hypertension | 1 | 2015 | 8614 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2010 | 3446 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2009 | 3236 | 0.010 |
Why?
|
Maternal Behavior | 1 | 1997 | 307 | 0.010 |
Why?
|
Endosonography | 1 | 1998 | 626 | 0.010 |
Why?
|
Health Care Costs | 1 | 2007 | 3241 | 0.010 |
Why?
|
Medicaid | 1 | 2008 | 2834 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2008 | 5337 | 0.010 |
Why?
|
Pediatrics | 1 | 2009 | 3613 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2000 | 4618 | 0.010 |
Why?
|
Sepsis | 1 | 2006 | 2604 | 0.010 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 1998 | 889 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1998 | 1308 | 0.010 |
Why?
|
Ischemia | 1 | 2000 | 1904 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2006 | 8619 | 0.010 |
Why?
|
India | 1 | 1997 | 2335 | 0.010 |
Why?
|
Rats | 1 | 2006 | 23718 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 17082 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2006 | 22337 | 0.000 |
Why?
|
Liver Cirrhosis | 1 | 1998 | 1960 | 0.000 |
Why?
|
Signal Transduction | 1 | 2010 | 23611 | 0.000 |
Why?
|
Stents | 1 | 1998 | 3191 | 0.000 |
Why?
|
Rural Population | 1 | 1997 | 2317 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36562 | 0.000 |
Why?
|
Heart Failure | 1 | 2000 | 11816 | 0.000 |
Why?
|